DURYSTA 10 ug/1 (Bimatoprost IMPLANT) 10 ug/1

DURYSTA 10 ug/1 is an intracameral implant containing bimatoprost, designed for ophthalmic use. It is commonly used to reduce intraocular pressure in patients with certain eye conditions. This implant is manufactured by Allergan, Inc. in the USA.

Strength

10 ug/1

Pack Size

1 IMPLANT in 1 POUCH (0023-9652-03)

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

DURYSTA 10 ug/1 is primarily used to manage intraocular pressure in the eye. It is often prescribed for conditions that require long-term pressure control. The implant works by enhancing the outflow of aqueous humor, which helps to maintain healthy eye pressure levels. Patients may wonder, 'What is DURYSTA used for?' and the answer lies in its ability to provide sustained pressure relief over time.

Side Effects

Common effects of DURYSTA 10 ug/1 may include temporary redness or irritation at the implantation site. Some users might experience mild discomfort or itching. These effects are generally short-lived and subside as the eye adjusts to the implant. It is important to monitor for any persistent or severe reactions and consult a healthcare provider if necessary.

Precautions & Warnings

Handling DURYSTA 10 ug/1 requires careful adherence to sterile procedures to avoid contamination. The implant should be stored and administered according to the instructions provided. Patients should be aware of any allergies to bimatoprost or similar compounds. Regular follow-ups with an eye care professional are recommended to ensure the implant is functioning as intended.

Avoid Interactions

DURYSTA 10 ug/1 may interact with other ophthalmic medications, particularly those used to treat glaucoma or other eye conditions. It is advisable to inform your healthcare provider about all current medications to avoid potential interactions. Alcohol and certain systemic medications might also affect the implant's efficacy or increase the risk of side effects.

Frequently Asked Questions

DURYSTA is used to manage intraocular pressure in the eye, often for conditions requiring long-term pressure control.

DURYSTA is administered as an intracameral implant by a healthcare professional.

Common side effects may include temporary redness, irritation, or mild discomfort at the implantation site.

DURYSTA is designed to provide sustained pressure relief over an extended period, typically several months.

It is important to consult a healthcare provider before using DURYSTA with other eye medications to avoid potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.